VivoSeq
Other

Quadratus Lumborum Block

0

Pipeline Programs

3

Active Trials

0

Companies Involved

Quadratus Lumborum Block is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

82/100

Attrition Rate

15/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

55

clinical trials

Completed37 · 67%
Unknown status7 · 13%
Terminated5 · 9%
Withdrawn3 · 5%
Not yet recruiting2 · 4%
Recruiting1 · 2%

Trial Activity

55 trials

Ultrasound Guided Anterior Quadratus Lumborum Block
Completed··N/A·NCT03425162·60 enrolled
Page 1 of 4

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)